Vaporous Hyperoxia Therapy (VHT) in the Treatment of Foot Wounds
Sponsored by Vaporox
About this trial
Last updated 5 years ago
Study ID
VAPOROX-VHT100-01
Status
Completed
Type
Interventional
Phase
N/A
Placebo
No
Accepting
18+ Years
All
Not accepting
Healthy Volunteers
Trial Timing
Ended 18 years ago
What is this trial about?
The purpose of this study is to evaluate the effectiveness of Vaporous Hyperoxia Therapy
(VHT), previously named Misty (WTS-1000) for the treatment of chronic foot ulcers.
What are the participation requirements?
Inclusion Criteria
- Diabetic, arterial, and venous foot ulcers as well as decubitus ulcers
- University of Texas Health Science Center classification: Grade 0, 1, and 2
Exclusion Criteria
- Ulcers above the medial and lateral malleoli
- Etiology of cancer/neoplastic
- Etiology of collagen vascular disease
- Etiology of gangrene
- Etiology of osteomyelitis (Grade 3)
- Etiology of thermal burns
- Etiology of radiation injury
- Pregnancy
- Acute skin conditions
- Inadequate perfusion to support treatment
- Wounds where the end cannot be probed
- Wounds covered with petroleum based dressing
- Non-compliant patients